Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
about
Cell-based therapy in lung regenerative medicineDelayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal modelMesenchymal stem cells in the treatment of chronic lung diseaseAutologous Stromal Vascular Fraction in the Intravenous Treatment of End-Stage Chronic Obstructive Pulmonary Disease: A Phase I Trial of Safety and Tolerability.Mesenchymal stem cell pretreatment of non-heart-beating-donors in experimental lung transplantation.The clinical use of regenerative therapy in COPDEffect of aged bone marrow microenvironment on mesenchymal stem cell migration.Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancerEthics and policy issues for stem cell research and pulmonary medicine.Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model.The role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent mannerGene-modified mesenchymal stem cells protect against radiation-induced lung injury.Mesenchymal stem cells with Sirt1 overexpression suppress breast tumor growth via chemokine-dependent natural killer cells recruitment.Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease.Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing.Experimental basis and new insights for cell therapy in Chronic Obstructive Pulmonary Disease.Impact of bone marrow-derived mesenchymal stem cells on remodeling the lung injury induced by lipopolysaccharides in mice.Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer.IL-1β-stimulated β-catenin up-regulation promotes angiogenesis in human lung-derived mesenchymal stromal cells through a NF-κB-dependent microRNA-433 induction.A new experimental model of cigarette smoke-induced emphysema in Wistar rats.Antioxidant Effects of Bone Marrow Mesenchymal Stem Cell against Carbon Tetrachloride-Induced Oxidative Damage in Rat Livers.Cholinergic and dopaminergic neuronal differentiation of human adipose tissue derived mesenchymal stem cells.Bone marrow transplantation improves the outcome of Atm-deficient mice through the migration of ATM-competent cells.Mesenchymal stem cells reduce cigarette smoke-induced inflammation and airflow obstruction in rats via TGF-β1 signaling.Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats.The functional study of human umbilical cord mesenchymal stem cells harbouring angiotensin-converting enzyme 2 in rat acute lung ischemia-reperfusion injury model.Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors.Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?
P2860
Q26852285-A7640681-6063-4B43-AF29-7A724EAD0780Q27301248-EAD13BB7-8E90-4594-86C6-C7133E741870Q28079373-CB09F2D7-8356-44B1-AEA3-4AF7188C2B83Q33893959-253DE781-48DC-4851-ABAF-D4D7245717C4Q34216196-5B8D0F6B-F699-431C-B08B-A0E5D6931574Q34456011-E5E7BBF4-ABD3-4C4C-9DCC-A6B2C708AE2BQ35096362-1AF0AC00-DDBB-4693-8BBD-1C78DDD5967EQ35107504-B7EB1519-4DF8-4A21-991D-CBB82FE9BE8FQ35190284-9AE0582E-CF12-424B-953F-1AF127FF5E3BQ36081902-F80FC1FA-BBDA-4EB3-8D6E-81499D4046ADQ36501020-FD611DC1-6EFE-4BD3-A45E-5B802AD902F1Q36673719-A30D7B33-4C51-48D4-8598-47985B967FD7Q37366958-24A82DB8-BAC9-47D6-9230-D499EA27AEE0Q37704669-B6B75948-94D1-4279-A8EE-2BA9357450B9Q37988753-17B5D28C-F74D-4EC5-8E2C-E14A56EAF594Q38051255-001BD3A2-B9E0-461F-90C2-308CE6B85C1AQ38739463-B7E4B36D-7BCB-4553-8A15-3AB6645D9B5AQ39339902-F18039EF-B040-42F2-A294-ABC7779D7A3EQ39569042-0D179A80-4751-429C-8084-4B4083037210Q41510622-A6DB8EF3-C287-4C9D-9AB8-2597F8B8D190Q42132908-CF471C04-67A2-481E-91C3-958A3ABDC653Q45056222-87127F03-4669-41E5-995E-03B3E5F1399AQ48320051-867A009B-1ACB-4AB9-9266-CB6343620D56Q51727837-6BC33F8C-0D2E-4601-856B-EAE37847672CQ52718255-C25B19AE-34C6-45FC-BED0-1C8ECDC94D88Q53019150-62924483-84FE-4781-9577-2E933DCE7A03Q54486116-39AD70BB-6999-4075-BD7A-4A25D7F20702Q58804261-290E8957-7C9D-4462-BD74-B0F3B95CFC05
P2860
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
@en
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
@nl
type
label
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
@en
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
@nl
prefLabel
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
@en
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
@nl
P2860
P50
P1476
Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease
@en
P2093
Antonella De Angelis
Francesco Rossi
P2860
P304
P356
10.1517/14712591003610614
P407
P577
2010-05-01T00:00:00Z